Cheviot Value Management LLC Has $3.75 Million Stake in CVS Health Co. (NYSE:CVS)

Cheviot Value Management LLC lifted its holdings in shares of CVS Health Co. (NYSE:CVS) by 4.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,435 shares of the pharmacy operator’s stock after buying an additional 2,461 shares during the quarter. CVS Health comprises approximately 0.7% of Cheviot Value Management LLC’s investment portfolio, making the stock its 28th biggest holding. Cheviot Value Management LLC’s holdings in CVS Health were worth $3,746,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of CVS. Capital International Investors grew its holdings in CVS Health by 47.4% during the fourth quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock valued at $2,660,298,000 after purchasing an additional 10,837,801 shares during the period. Pzena Investment Management LLC grew its holdings in CVS Health by 132.9% during the second quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after purchasing an additional 7,382,931 shares during the period. Capital World Investors grew its holdings in CVS Health by 8.0% during the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after purchasing an additional 3,232,172 shares during the period. State of Michigan Retirement System grew its holdings in CVS Health by 402.5% during the second quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock valued at $118,455,000 after purchasing an additional 1,606,500 shares during the period. Finally, Junto Capital Management LP acquired a new position in CVS Health during the fourth quarter valued at approximately $111,209,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on CVS. Robert W. Baird began coverage on shares of CVS Health in a report on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective for the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Monday, September 16th. Evercore ISI reduced their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. JPMorgan Chase & Co. reduced their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Finally, Barclays reduced their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. Eleven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $72.10.

CVS Health Stock Performance

NYSE CVS opened at $57.57 on Tuesday. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The firm’s fifty day moving average price is $58.28 and its two-hundred day moving average price is $62.32. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The firm has a market capitalization of $72.27 billion, a P/E ratio of 10.12, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. As a group, research analysts anticipate that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.62%. The ex-dividend date is Monday, October 21st. CVS Health’s payout ratio is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.